Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017105
Sloan Kettering Institute
Search grants from Sloan Kettering Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Bedside-to-Bench Research Training for Pediatric Infectious Diseases Fellows
Epidemiology and Laboratory Capacity for Infectious Diseases
Medical Mycology Predoctoral Training Program
Improving Quality of Life in Elders with Medical Illness
Oligosaccharide Conformations and Their Interactions with Proteins.
Recently added grants:
Identifying integrated circuit mechanisms of PTSD: Multimodal neuroimaging fusion of fear inhibition and cognitive control
Targeting Chemoreceptor Control of Breathing during Sleep to Mitigate Opioid-Associated Sleep Disordered Breathing
Validation of Mesoscopic Imaging to Predict Cutaneous Carcinogenesis and its Therapeutic Response
Understanding and targeting stress reactivity in women Veterans with alcohol misuse
CPT-SMART for Treatment of PTSD and Cigarette Smoking
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017105-008
Application #
6994628
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
Sloan Kettering Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
Comments
Be the first to comment on this grant